Sanofi
41.60USD
-0.3600 (-0.86%)
Fetching financial statements from SEC filings…
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on SNY.
| In EUR M except per-share | Q2 FY26 | Q1 FY26 | Q4 FY25 | Q3 FY25 | Q2 FY25 |
|---|---|---|---|---|---|
| Revenue | 12,300 | 11,244 | 12,205 | 13,170 | 10,735 |
| Cost of Revenue | 3,017 | 3,138 | 3,756 | 3,412 | 2,993 |
| Gross Profit | 9,283 | 8,106 | 8,449 | 9,758 | 7,742 |
| Operating Income | 2,384 | 2,269 | 1,630 | 3,785 | 1,940 |
| Net Income | 343 | 1,614 | -801 | 2,802 | 3,939 |
| EPS (Diluted) | €0.14 | €0.67 | -€0.33 | €1.15 | €1.62 |
Source: Yahoo Finance (limited history)